Robert F. Kennedy Jr., the new U.S. Secretary of Health and Human Services, is highly supportive of telehealth technology. Hydreight Technologies (TSXV: NURS) is ideally positioned to lead in this emerging sector.
Hydreight is often referred to as the "Uber for Nurses"—a revolutionary mobile telehealth platform enabling patients to book licensed healthcare professionals directly to their home, hotel, or office.
Hydreight’s revenue has consistently increased quarter-over-quarter:
Hydreight’s proprietary platform integrates Electronic Medical Records, telemedicine, e-commerce, and charting into a seamless mobile network. It empowers nurses to operate their own healthcare businesses legally and efficiently in all 50 states.
Over 3,000 nurses and 100+ doctors are already part of Hydreight’s nationwide clinical network.
Hydreight now provides low-cost access to Semaglutide—including a needle-free sublingual version—and a full suite of new oral weight loss therapies launched February 27th:
Three delivery formats available: sublingual, capsules, and tablets.
NURS has rapidly grown into a telehealth powerhouse, offering services in multiple high-growth sectors: GLP-1s, peptides, anti-aging, NAD+, hair loss, and sexual wellness.
Hydreight recently partnered with global endocrinologist Dr. Franklin Joseph to launch "Dr. Frank’s Method" weight loss brand in the U.S. through its VSDHOne platform. This partnership will help Hydreight capture a significant portion of the $400B weight-loss market by 2030.
Ranked #56 on Deloitte’s Technology Fast 500™ and #13 by Financial Times among America’s fastest-growing companies.
Hydreight Technologies (TSXV: NURS) is at the forefront of digital healthcare, combining innovation, compliance, and mobile accessibility to address systemic inefficiencies in the $4.9 trillion U.S. healthcare market.
For investors seeking scalable, high-growth exposure to the telehealth revolution, NURS represents a compelling opportunity. The company’s success in licensing, revenue generation, and strategic partnerships sets the foundation for long-term value creation.
Visit: www.hydreight.com
Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. NIA has received compensation from NURS of US$30,000 cash for a three-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.
Preparing Americans for Hyperinflation